India To Unveil Synthetic Alternative To Artemisinin For Treating Malaria
This article was originally published in PharmAsia News
Indian officials plan to unveil a locally developed synthetic alternative to the prevailing plant-based malaria treatment, artemisinin, which is encountering increasingly resistant strains of the disease.
You may also be interested in...
Dr Reddy’s management clears air on ransomware attack and says all critical operations are being enabled in a 'controlled and cautious' manner. The Indian firm also shared a timeline for its partnered Russian COVID-19 vaccine amid a free supply chorus in India.
Regardless of who wins, China seems to be looking beyond the 3 November US General Election, instead pouring in large resources to elevate its domestic health sector on a par with international standards, creating opportunities and profoundly impacting many areas from novel therapy development to investment decisions.
Edwards Lifesciences has slashed the number of open CAPAs at its Draper, UT, manufacturing site by more than half. See what the company’s director of quality engineering, Dan Buehner, said about it here.